Related Experiment Video
Updated: Jun 3, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Postoperative course and recurrence of chronic subdural hematoma
Hyuck-Jin Oh1, Kyeong-Seok Lee, Jae-Jun Shim
1Department of Neurosurgery, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.
Insights
Recurrence of chronic subdural hematoma (CSDH) is common. This study proposes new criteria for early recurrence (within 3 months) and late recurrence (beyond 3 months) to better manage CSDH patients.
Area of Science:
- Neurosurgery
- Radiology
- Neurology
Background:
- Chronic subdural hematoma (CSDH) presents a significant challenge due to its high recurrence rate.
- Current criteria for defining CSDH recurrence lack standardization, complicating patient management and outcome assessment.
Purpose of the Study:
- To evaluate the postoperative course of chronic subdural hematoma (CSDH).
- To propose refined criteria for defining CSDH recurrence based on clinical and radiological findings.
Main Methods:
- Retrospective analysis of 149 patients who underwent CSDH surgery between 2005 and 2009.
- Review of medical records and pre- and postoperative CT scans to assess resolution and recurrence patterns.
Main Results:
- CSDH resolved within 30 days in 39% of patients, 1-3 months in 42%, and after 3 months in 7%.
- Recurrence occurred in 12% of patients, with thicker hematomas showing higher recurrence rates.
- Late resolution or recurrence was more frequent in elderly patients.
Conclusions:
- Proposed criteria define early recurrence as symptom return or reaccumulation within 3 months post-surgery.
- Late recurrence is defined as reappearance or enlargement of a liquefied hematoma or persistent CSDH beyond 3 months.
Objective:
Chronic subdural hematoma (CSDH) is known to have a significant recurrence rate. There are different criteria defining the recurrence of CSDH. We evaluated the postoperative course of CSDH and tried to propose the reasonable criteria of recurrence.
Methods:
We retrospectively examined the medical records and pre- and postoperative CT scans of 149 consecutive patients who underwent surgery from January 2005 to December 2009. Diagnosis was confirmed by CT scanning or MRI. The postoperative courses were either resolved or recurrent. The resolved CSDH was one of the three types; early resolution, delayed resolution, or late resolution. The recurrent CSDH was one of the four types; recurrence without resolution, early recurrence after resolution, late recurrence after resolution, or recurrent-and-resolved type.
Results:
The CSDH was resolved within 30 days after surgery in 58 (39%) patients, between 1 to 3 months in 62 (42%), and after 3 months in 11 (7%) patients. The CSDH was recurred in 18 (12%) patients. Late resolution or recurrence was more common in the aged. The recurrent hematoma was seen on the same side in 11 patients, on the different side in 7 patients. Recurrence was significantly more common in the thick hematomas.
Conclusion:
For a working criteria of the recurrence of CSDH, we propose the early recurrence as return of symptoms or reaccumulation of the hematoma after a surgery within 3 months regardless of the location, amount or repeated operations. The late recurrence can be defined as reappearance or enlargement of a liquefied hematoma within the cranial cavity surrounded by the membranes or persistent CSDH beyond 3 months after surgery.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Peripheral Artery Disease V: Postoperative Nursing Management
Pulmonary Embolism III: Nursing Management